Use of Surrogate End Points in Healthcare Policy: A Proposal for Adoption of a Validation Framework

Nature Reviews Drug Discovery - United Kingdom
doi 10.1038/nrd.2016.81
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Validation of Surrogate End Points for Overall Survival in Advanced Colorectal Cancer: A Harmonized Approach Is Needed

Journal of Clinical Epidemiology
Epidemiology
2016English

A Framework Proposal for Analysis of Urbanization Policy

European Scientific Journal, ESJ
2017English

Designing a Roadmap Framework for Healthcare Systems Adoption

2019English

Surrogate End Points for Clinical Trials of Kidney Disease Progression

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2006English

A Proposal of Indicators and Policy Framework for Innovation Benchmark in Europe

Journal of Technology Management and Innovation
Management of TechnologyInnovation
2010English

Time to Review the Role of Surrogate End Points in Health Policy: State of the Art and the Way Forward

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-Points (ECLIPSE)

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2008English

Validation of 6-Minute Walk Distance as a Surrogate End Point in Pulmonary Arterial Hypertension Trials

Circulation
Cardiovascular MedicinePhysiologyCardiology
2012English

a Blockchain-Based Service Provider Validation and Verification Framework for Healthcare Virtual Organization

UHD Journal of Science and Technology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy